<VariationArchive VariationID="1074900" VariationName="NM_206933.4(USH2A):c.675_678del (p.Phe225fs)" VariationType="Deletion" Accession="VCV001074900" Version="9" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-02-28" DateCreated="2021-05-10" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1058647" VariationID="1074900">
      <GeneList>
        <Gene Symbol="USH2A" FullName="usherin" GeneID="7399" HGNC_ID="HGNC:12601" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q41</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="215622891" stop="216423448" display_start="215622891" display_stop="216423448" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="215796235" stop="216596737" display_start="215796235" display_stop="216596737" Strand="-" />
          </Location>
          <OMIM>608400</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_206933.4(USH2A):c.675_678del (p.Phe225fs)</Name>
      <CanonicalSPDI>NC_000001.11:216365058:AAAGAA:AA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1q41</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="216365059" stop="216365062" display_start="216365059" display_stop="216365062" variantLength="4" positionVCF="216365058" referenceAlleleVCF="TAAAG" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="216538401" stop="216538404" display_start="216538401" display_stop="216538404" variantLength="4" positionVCF="216538400" referenceAlleleVCF="TAAAG" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>F225fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.216538403_216538406del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.216538403_216538406del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.216365061_216365064del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.216365061_216365064del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009497.2" sequenceAccession="NG_009497" sequenceVersion="2" change="g.63387_63390del">
            <Expression>NG_009497.2:g.63387_63390del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_007123.6" sequenceAccession="NM_007123" sequenceVersion="6" change="c.675_678del">
            <Expression>NM_007123.6:c.675_678del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_009054.6" sequenceAccession="NP_009054" sequenceVersion="6" change="p.Phe225fs">
            <Expression>NP_009054.6:p.Phe225fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_206933.4" sequenceAccession="NM_206933" sequenceVersion="4" change="c.675_678del" MANESelect="true">
            <Expression>NM_206933.4:c.675_678del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_996816.3" sequenceAccession="NP_996816" sequenceVersion="3" change="p.Phe225fs">
            <Expression>NP_996816.3:p.Phe225fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_206933.4" sequenceAccession="NM_206933" sequenceVersion="4" change="c.675_678delCTTT" MANESelect="true">
            <Expression>NM_206933.4:c.675_678delCTTT</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2102708663" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_206933.4(USH2A):c.675_678del (p.Phe225fs) AND not provided" Accession="RCV001388346" Version="4">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-07-06" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_206933.4(USH2A):c.675_678del (p.Phe225fs) AND Usher syndrome type 2A" Accession="RCV002307743" Version="5">
        <ClassifiedConditionList TraitSetID="594">
          <ClassifiedCondition DB="MedGen" ID="C1848634">Usher syndrome type 2A</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-11-04" SubmissionCount="3">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-11-04" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2021-05-10" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10729113</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">10909849</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20507924</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25649381</ID>
        </Citation>
        <DescriptionHistory Dated="2022-11-18">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="594" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6097" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Usher syndrome type 2A</ElementValue>
                <XRef ID="MONDO:0010169" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">USHER SYNDROME, TYPE IIA</ElementValue>
                <XRef Type="MIM" ID="276901" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0014" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0015" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0011" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">RETINAL DISEASE IN USHER SYNDROME TYPE IIA, MODIFIER OF</ElementValue>
                <XRef Type="Allelic variant" ID="612971.0001" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">USH2A</ElementValue>
                <XRef Type="MIM" ID="276901" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">USH2</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">US2</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Usher syndrome type II (USH2) is characterized by the following: Congenital, bilateral sensorineural hearing loss that is mild to moderate in the low frequencies and severe to profound in the higher frequencies. Intact or variable vestibular responses. Retinitis pigmentosa (RP); progressive, bilateral, symmetric retinal degeneration that begins with night blindness and constricted visual fields (tunnel vision) and eventually includes decreased central visual acuity; the rate and degree of vision loss vary within and among families.</Attribute>
                <XRef ID="NBK1341" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5440" />
                <XRef ID="5440" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15241" />
                <XRef ID="15241" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301515</ID>
                <ID Source="BookShelf">NBK1341</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="PubMed">21697857</ID>
              </Citation>
              <XRef ID="231178" DB="Orphanet" />
              <XRef ID="886" DB="Orphanet" />
              <XRef ID="C1848634" DB="MedGen" />
              <XRef ID="MONDO:0010169" DB="MONDO" />
              <XRef Type="MIM" ID="276901" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5084057" SubmissionDate="2022-11-17" DateLastUpdated="2022-12-24" DateCreated="2022-11-19">
        <ClinVarSubmissionID localKey="12762464|OMIM:276901" />
        <ClinVarAccession Accession="SCV002604301" DateUpdated="2022-12-24" DateCreated="2022-11-19" Type="SCV" Version="2" SubmitterName="Myriad Genetics, Inc." OrgID="507240" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-02-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>NM_206933.2(USH2A):c.675_678delCTTT(F225Lfs*17) is expected to be pathogenic in the context of USH2A-related disorders. This variant is predicted to lead to an abnormal or absent protein product due to the creation of a premature termination codon in USH2A, a gene where loss-of-function variants are known to be pathogenic. Please note: this variant was assessed in the context of healthy population screening.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Myriad Women's Health Autosomal Recessive and X-Linked Classification Criteria (2021)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/wpe7ty9o/myriad_women_s_health_autosomal_recessive_and_x-linked_classification_criteria_2021_.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="USH2A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="1" alternateAllele="T" referenceAllele="TAAAG" start="216538400" stop="216538404" />
          </Location>
          <OtherNameList>
            <Name Type="SubmitterVariantId">12762464</Name>
          </OtherNameList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="276901" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12292560</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7197013" SubmissionDate="2023-04-06" DateLastUpdated="2023-04-09" DateCreated="2023-04-09">
        <ClinVarSubmissionID localKey="SUB13035132" submittedAssembly="hg19" title="SUB13035132" />
        <ClinVarAccession Accession="SCV003853260" DateUpdated="2023-04-09" DateCreated="2023-04-09" Type="SCV" Version="1" SubmitterName="Lifecell International Pvt. Ltd" OrgID="507720" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>A Heterozygous Frameshift variant c.675_678delCTTT in Exon 4 of the USH2A gene that results in the premature termination of the protein (p.Phe225fs*17) was identified. The observed variant has a minimum allele frequency of 0.00% in gnomAD exomes and genomes, respectively. The severity of the impact of this variant on the protein is high, based on the effect of the protein and REVEL score . Rare Exome Variant Ensemble Learner (REVEL) is an ensembl method for predicting the pathogenicity of missense variants based on a combination of scores from 13 individual tools: MutPred, FATHMM v2.3, VEST 3.0, PolyPhen-2, SIFT, PROVEAN, MutationAssessor, MutationTaster, LRT, GERP++, SiPhy, phyloP, and phastCons. The REVEL score for an individual missense variant can range from 0 to 1, with higher scores reflecting greater likelihood that the variant is disease-causing. The variant was found in ClinVar (Variant ID :1074900) with a classification of Pathogenic/Likely Pathogenic and a review status of (2 star) criteria provided, multiple submitters, no conflicts.. Based on the above evidence this variant has been classified as Pathogenic according to the ACMG guidelines.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>Asian</Ethnicity>
              <GeographicOrigin>India</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <NamePlatform>NovaSeq 6000</NamePlatform>
              <TypePlatform>Next-generation exome sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="CompoundHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="USH2A">
              <Name>usherin</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_206933.4:exon 4</GeneLocation>
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_206933.4:c.675_678delCTTT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="276901" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13035132</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7821995" SubmissionDate="2023-12-17" DateLastUpdated="2023-12-24" DateCreated="2023-12-24">
        <ClinVarSubmissionID localKey="NM_206933.4:c.675_678del|OMIM:276901" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004182960" DateUpdated="2023-12-24" DateCreated="2023-12-24" Type="SCV" Version="1" SubmitterName="Genome-Nilou Lab" OrgID="507598" OrganizationCategory="laboratory" OrgAbbreviation="Genome Nilou" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>no</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="USH2A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_206933.4:c.675_678del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="276901" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14095489</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3114945" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="11782659|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001589281" DateUpdated="2024-02-28" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-07-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10729113</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10909849</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20507924</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25649381</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1074900). This variant has not been reported in the literature in individuals affected with USH2A-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Phe225Leufs*17) in the USH2A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in USH2A are known to be pathogenic (PMID: 10729113, 10909849, 20507924, 25649381).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="USH2A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.216538401_216538404del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3114945" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7821995" TraitType="Disease" MappingType="XRef" MappingValue="276901" MappingRef="OMIM">
        <MedGen CUI="C1848634" Name="Usher syndrome type 2A" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5084057" TraitType="Disease" MappingType="XRef" MappingValue="276901" MappingRef="OMIM">
        <MedGen CUI="C1848634" Name="Usher syndrome type 2A" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7197013" TraitType="Disease" MappingType="XRef" MappingValue="276901" MappingRef="OMIM">
        <MedGen CUI="C1848634" Name="Usher syndrome type 2A" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

